The in vitro and in vivo effects of re-expressing methylated von Hippel-Lindau tumor suppressor gene in clear cell renal carcinoma with 5-aza-2'-deoxycytidine
| Autor: | Wade G, Alleman, Ray L, Tabios, Gadisetti V R, Chandramouli, Olga N, Aprelikova, Carlos, Torres-Cabala, Arnulfo, Mendoza, Craig, Rogers, Craig, Rodgers, Nikolai A, Sopko, W Marston, Linehan, James R, Vasselli |
|---|---|
| Rok vydání: | 2004 |
| Předmět: |
Antimetabolites
Antineoplastic Reverse Transcriptase Polymerase Chain Reaction Tumor Suppressor Proteins Ubiquitin-Protein Ligases Transplantation Heterologous Cytidine DNA Methylation Decitabine Pyrimidine Nucleosides Transfection Kidney Neoplasms Disease Models Animal Mice Von Hippel-Lindau Tumor Suppressor Protein Azacitidine Tumor Cells Cultured Animals Humans Gene Silencing Adenocarcinoma Clear Cell |
| Zdroj: | Clinical cancer research : an official journal of the American Association for Cancer Research. 10(20) |
| ISSN: | 1078-0432 |
| Popis: | Clear cell renal carcinoma (ccRCC) is strongly associated with loss of the von Hippel-Lindau (VHL) tumor suppressor gene. The VHL gene is functionally lost through hypermethylation in up to 19% of sporadic ccRCC cases. We theorized that re-expressing VHL silenced by methylation in ccRCC cells, using a hypo-methylating agent, may be an approach to treatment in patients with this type of cancer. We test the ability of two hypo-methylating agents to re-express VHL in cell culture and in mice bearing human ccRCC and evaluate the effects of re-expressed VHL in these models.Real-time reverse transcription-PCR was used to evaluate the ability of zebularine and 5-aza-2'-deoxycytidine (5-aza-dCyd) to re-express VHL in four ccRCC cell lines with documented VHL gene silencing through hypermethylation. We evaluated if the VHL re-expressed after hypo-methylating agent treatment could recreate similar phenotypic changes in ccRCC cells observed when the VHL gene is re-expressed via transfection in cell culture and in a xenograft mouse model. Finally we evaluate global gene expression changes occurring in our cells, using microarray analysis.5-Aza-dCyd was able to re-express VHL in our cell lines both in culture and in xenografted murine tumors. Well described phenotypic changes of VHL expression including decreased invasiveness into Matrigel, and decreased vascular endothelial growth factor and glucose transporter-1 expression were observed in the treated lines. VHL methylated ccRCC xenografted tumors were significantly reduced in size in mice treated with 5-aza-dCyd. Mice bearing nonmethylated but VHL-mutated tumors showed no tumor shrinkage with 5-aza-dCyd treatment.Hypo-methylating agents may be useful in the treatment of patients having ccRCC tumors consisting of cells with methylated VHL. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|